MRNA Jan 2025 50.000 call
| Previous close | 74.78 |
| Open | 74.78 |
| Bid | 69.30 |
| Ask | 71.05 |
| Strike | 50.00 |
| Expiry date | 2025-01-17 |
| Day's range | 74.78 - 74.78 |
| Contract range | N/A |
| Volume | |
| Open interest | 48 |
- Yahoo Finance Video
Consumer sentiment drops, Tesla's Supercharger, Zeekr IPO: Catalysts
The University of Michigan's Consumer Sentiment Index reported that preliminary data for the month of May fell below estimates, a six-month low of 67.4, which could complicate the Federal Reserve's mission to drive inflation down to 2%. Artificial intelligence developer OpenAI is reportedly developing an AI-powered search engine that could rival Alphabet's Google (GOOGL, GOOG), and it could drop as early as Monday, May 13 according to Reuters. Path Trading Partners Co-Founder and Chief Market Strategist Bob Iaccino joins Catalysts to detail how Fed interest rate cuts and asset inflation could fuel a jump in gold futures (GC=F). Gartner Vice President and Team Manager of Automotives, Transportation, and Cross Manufacturing Mike Ramsey also sits down to explain the future of Tesla's (TSLA) Supercharger network and the EV maker's plans for its full self-driving autonomous vehicles down the line. Other notable guests this hour include Santander US CEO Tim Wennes (SAN) and Gen Digital CEO Vincent Pilette (GEN). This post was written by Luke Carberry Mogan.
Investor's Business DailyModerna Seesaws After The FDA Throws A Curveball On Its Second Product
Moderna stock seesawed Friday after the Food and Drug Administration delayed an approval decision on its RSV vaccine until the end of the month.
Barrons.comFDA Delays Decision on Moderna RSV Shot by 3 Weeks
The agency was originally scheduled to announce its call on Sunday. The company said it hadn’t flagged any issues with the drug’s safety, efficacy, or quality.
